Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of bosentan on sympathetic activity and chemoreflex
2006-003133-33Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of bosentan, sponsored by Erasmus Hospital. Primary endpoint: Peripheral chemoreflex sensitivity decrease. Started Jul 2006; status: completed.
02
Drugs
bosentan
Beyond the preview
Go deeper on 2006-003133-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003133-33.